SCHEMBL4192197

SCHEMBL4192197

Cc1cccc2nc(-c3cccc4ccccc34)oc(=O)c12

nearest known ligand 0.71

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
C1R P00736 1/20 0.71
ELANE P08246 18/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8006834 0.90 C1R (0.81) C1RELANE
SCHEMBL4190607 0.83 ELANE (0.79) C1RELANE
SCHEMBL5254274 0.83 ELANE (0.66) C1RELANE
SCHEMBL2816912 0.82 C1R (0.69) C1RELANE
SCHEMBL914656 0.81 ELANE (0.76) C1RELANE
SCHEMBL4185334 0.80 ELANE (0.60) C1RELANE
SCHEMBL283356 0.80 ELANE (0.72) C1RELANE
SCHEMBL914212 0.80 ELANE (0.68) C1RELANE
SCHEMBL8210285 0.80 ELANE (1.00) C1RELANE
SCHEMBL8016730 0.79 ELANE (0.76) C1RELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1756044-A1 THERAPEUTIC COMPOUNDS AstraZeneca AB (SE) 2007-02-28 EP disclosed
WO-2005115972-A1 THERAPEUTIC COMPOUNDS ASTRAZENECA AB (SE) 2005-12-08 WO disclosed